Possible Game Changer in Treating Uncontrolled Blood Pressure
Keith Benzuly, MD, a cardiologist and the principal investigator of this trial at Northwestern’s Bluhm Cardiovascular Institute, spoke with the Wall Street Journal about how the trial focuses on patients with high blood pressure who don’t benefit from these hypertension medications. Benzuly commented, “They don’t have any other identifiable, treatable causes of high blood pressure. That has been frustrating for patients for years.”
To learn more, view the full Wall Street Journal article*.